Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents [Phase 1]
Phase 1 safety study of sublingual immunotherapy tablets containing house dust mite allergen extract in adolescents with allergic rhinitis. …
-
FDA label_change · 2025-01-10FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Children's Flonase Allergy Relief (fluticasone propionate) by Haleon US Holdings LLC.
-
FDA label_change · 2025-01-10FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Flonase Sensimist Allergy Relief (fluticasone furoate) by Haleon US Holdings LLC to update t…
-
CLINICAL_TRIALS other · 2025-01-09Clinical Trial Update: Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis [NA]
Clinical trial update for Breathe-Easy Hayfever Care in seasonal allergic rhinitis; status shows completed, with no results details provided…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Health Effects of Wood Smoke and Traffic-Related Air Pollution Exposures: a Necessary Comparison [NA]
This clinical trial update describes a study comparing health effects of wood smoke and traffic-related air pollution exposures. It includes…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Microbial Study of Sublingual Immunotherapy Tablets in Patients With Allergic Rhinitis
Clinical trial update describing a microbial study of sublingual immunotherapy tablets for allergic rhinitis; the study is not yet recruitin…
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Microbial Study of Sublingual Immunotherapy Spray in Patients With Allergic Rhinitis
This update describes a microbial study of sublingual immunotherapy spray for allergic rhinitis and notes that the trial is not yet recruiti…
-
FDA approval · 2024-12-17FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) submitted by Viatris Specialty LLC…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis [Phase 3]
Phase 3 trial update in adults with grass pollen-induced rhinoconjunctivitis; results have been posted after study completion.
-
FDA approval · 2024-12-12FDA Approved: FLUNISOLIDE — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for Flunisolide by Bausch & Lomb, approving changes related to this product under the ANDA. This…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites [NA]
Clinical trial exploring how ZhenQiFuZheng may treat allergic rhinitis by influencing gut microbiota and metabolites. The study is currently…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Effect of a Multistrain Probiotic on Allergic Rhinitis Symptoms and Gut Microbiota Composition in Atopic Patients [NA]
A completed clinical trial evaluating whether a multistrain probiotic affects allergic rhinitis symptoms and gut microbiota in atopic patien…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Study on the Effect and Mechanism of Aescine Sodium in the Treatment of Allergic Rhinitis [NA]
Clinical trial update on the effect and mechanism of Aescine Sodium for allergic rhinitis. The study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Impacts of Nitrogen Deposition in the Natural Environment on Pollen Allergy in Belgium [NA]
A Belgian clinical trial investigating how environmental nitrogen deposition affects pollen allergy is currently recruiting participants.
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Study on the Effect and Mechanism of Lupatadine Fumarate in the Treatment of Allergic Rhinitis [NA]
A clinical trial investigating the efficacy and mechanism of Lupatadine Fumarate for allergic rhinitis; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Evaluating the Potential of Large Language Models for Respiratory Disease Consultations [NA]
This completed clinical trial evaluated the potential of large language models to assist respiratory disease consultations. It covered multi…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis [Phase 1]
A Phase 1 trial evaluating TQC3564 tablets for persistent allergic rhinitis has been terminated.
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Lacticaseibacillus Rhamnosus LRa05 for Alleviating Allergic Rhinitis in Children [NA]
A clinical trial update for the probiotic LRa05 (Lacticaseibacillus rhamnosus LRa05) investigating its potential to alleviate allergic rhini…
-
FDA approval · 2024-11-21FDA Approved: LORATADINE 10 MG — Original Application (TIME CAP LABORATORIES, INC.)
FDA approved Time Cap Laboratories, Inc.'s loratadine 10 mg tablets via an original ANDA, establishing a generic version of the antihistamin…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants [Phase 2]
Phase 2 trial evaluating subcutaneous anti-Bet v 1 monoclonal antibodies showed efficacy in reducing allergic rhinitis and conjunctivitis sy…
-
FDA approval · 2024-11-15FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) by Kenvue Brands LLC. The approval adds or expands the…
-
FDA approval · 2024-11-13FDA Approved: CHILDRENS ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Children's Zyrtec (cetirizine hydrochloride) by Kenvue Brands LLC. The approval pertains to a mo…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Study of CM310 in Subjects With Allergic Rhinitis [Phase 3]
A Phase 3 clinical trial evaluating CM310 for allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Study of CM310 in Patients With Allergic Rhinitis [Phase 2]
Phase 2 clinical trial evaluating CM310 in allergic rhinitis has completed.
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Study of Stapokibart Injection in Patients With Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial evaluating Stapokibart Injection for allergic rhinitis is currently recruiting.